Filing Details

Accession Number:
0001367644-21-000144
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-15 17:53:15
Reporting Period:
2021-11-15
Accepted Time:
2021-11-15 17:53:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1367644 Emergent Biosolutions Inc. EBS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1196632 S Richard Lindahl 400 Professional Drive, Suite 400
Gaithersburg MD 20879
Evp, Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-15 3,000 $37.46 39,919 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $37.32 to $37.63.